0001815476-22-000005.txt : 20220214 0001815476-22-000005.hdr.sgml : 20220214 20220214110338 ACCESSION NUMBER: 0001815476-22-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220214 DATE AS OF CHANGE: 20220214 EFFECTIVENESS DATE: 20220214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Braxia Scientific Corp. CENTRAL INDEX KEY: 0001815476 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-433478 FILM NUMBER: 22627135 BUSINESS ADDRESS: STREET 1: 2300 - 1177 WEST HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6E2K3 BUSINESS PHONE: 6045259409 MAIL ADDRESS: STREET 1: 2300 - 1177 WEST HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6E2K3 FORMER COMPANY: FORMER CONFORMED NAME: Champignon Brands Inc. DATE OF NAME CHANGE: 20200618 D 1 primary_doc.xml X0708 D LIVE 0001815476 Braxia Scientific Corp. 1430 Hurontario Street Mississauga A6 ONTARIO, CANADA L5G 3H4 416 762-2138 BRITISH COLUMBIA, CANADA Champignon Brands Inc. Corporation true 2018 Roger McIntyre 1430 Hurontario Street Mississauga A6 ONTARIO, CANADA L5G 3H4 Executive Officer Director Stephen Brooks 1430 Hurontario Street Mississauga A6 ONTARIO, CANADA L5G 3H4 Executive Officer Peter Rizakos 1430 Hurontario Street Mississauga A6 ONTARIO, CANADA L5G 3H4 Executive Officer Olga Cwiek 1430 Hurontario Street Mississauga A6 ONTARIO, CANADA L5G 3H4 Director Jerry Habuda 1430 Hurontario Street Mississauga A6 ONTARIO, CANADA L5G 3H4 Director David Greenberg 1430 Hurontario Street Mississauga A6 ONTARIO, CANADA L5G 3H4 Director Pharmaceuticals $1,000,001 - $5,000,000 06b false 2022-01-10 true true true true true Each unit consists of one common share and one common share purchase warrant. Each warrant is exercisable for one common share at an exercise price of CAD$0.125 per share for five years. false 0 H.C. Wainwright and Co., LLC 375 None None 430 Park Avenue 4th Floor New York NY NEW YORK 10022 FL FLORIDA NJ NEW JERSEY NY NEW YORK false 5323763 2366078 2957685 The additional $2,957,685 may be received upon the exercise of share purchase warrants sold inside or outside the U.S. The dollar amounts are based on the Bank of Canada average rate of exchange reported on 1/10/2022, which was CAD $1.2679=USD$1.00. false 4 372664 0 Includes broker warrants to purchase 2,100,000 common shares of the issuer at CAD$0.125 per share for a period of five years. 0 In the ordinary course of business the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false Braxia Scientific Corp. Peter Rizakos Peter Rizakos Chief Legal Officer 2022-02-14